<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318316</url>
  </required_header>
  <id_info>
    <org_study_id>EBC01</org_study_id>
    <nct_id>NCT02318316</nct_id>
  </id_info>
  <brief_title>&quot;Exhaled Breath Condensate&quot; in Allogeneic Stem Cell Recipients and the Value in Follow-up</brief_title>
  <official_title>&quot;Exhaled Breath Condensate&quot; in Allogeneic Stem Cell Recipients and Value in Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tubitak</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gazi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The most effective treatment of hematologic malignancies and some benign hematological
      diseases is allogeneic stem cell transplantation therapy. Pulmonary complications can occur
      after allogeneic stem cell transplantation. And these complications effect mortality and
      morbidity in these patients. In this study we want to investigate the use of exhaled breath
      condensate (EBC) collection which is a simple and completely noninvasive method. By this way
      we hope to detect pulmonary complications early. EBC, has been implicated in the
      pathophysiology of inflammatory airway diseases such as cystic fibrosis, asthma, chronic
      obstructive pulmonary disease (COPD) and bronchiectasis. EBC, has not been investigated
      before in patients who underwent stem cell transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The pH level of exhaled breath condansate</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The nitrotyrosine and 8-isoprostane levels of exhaled breath condansate</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Exhaled Breath Condensate</condition>
  <arm_group>
    <arm_group_label>EBC level</arm_group_label>
    <description>Exhaled breath condensate level of allogeneic stem cell transplantation patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exhaled breath condensate</intervention_name>
    <description>Breath condensate samples will be collected with a commercially available condenser (EcoScreen®, Erich Jaeger, Germany). Subjects will breathe through a mouthpiece and a two-way non-rebreathing value in which inspiratory and expiratory air were separated, and saliva was trapped. They will be asked to breathe at a normal frequency and tidal volume for 15 minutes while wearing nose clips, allowing collection of 1.5-2.5 mL of condensate. After collecting this, pH will be measured and the waste collection will be stored at -80 degrees. Then 8 isoprostane and nitrotyrosine will be measured collectively</description>
    <arm_group_label>EBC level</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        allogeneic stem cell transplantation patients for hematologic malignancies and some benign
        hematological diseases
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hematologic malignancies or benign hematological diseases that allogeneic stem cell
             transplantation performed

        Exclusion Criteria:

          -  allogeneic stem cell transplantation patients with Asthma or COPD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zeki Yıldırım, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University Faculty of Medicine Chest Disease Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nilgün Yilmaz Demirci, MD</last_name>
    <phone>009031224143</phone>
    <email>nilgundemirci@gazi.edu.tr</email>
  </overall_contact>
  <reference>
    <citation>Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfeld J, Jöbsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin AC, Redington AE, Reinhold P, van Rensen EL, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C, Wirtz H; ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005 Sep;26(3):523-48.</citation>
    <PMID>16135737</PMID>
  </reference>
  <reference>
    <citation>Dupont LJ, Dewandeleer Y, Vanaudenaerde BM, Van Raemdonck DE, Verleden GM. The pH of exhaled breath condensate of patients with allograft rejection after lung transplantation. Am J Transplant. 2006 Jun;6(6):1486-92.</citation>
    <PMID>16686775</PMID>
  </reference>
  <reference>
    <citation>Mo XD, Xu LP, Liu DH, Zhang XH, Chen H, Chen YH, Han W, Wang Y, Wang FR, Wang JZ, Liu KY, Huang XJ. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation. Chin Med J (Engl). 2013 Jul;126(13):2489-94.</citation>
    <PMID>23823823</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2014</study_first_submitted>
  <study_first_submitted_qc>December 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>December 16, 2014</last_update_submitted>
  <last_update_submitted_qc>December 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Nilgün Yılmaz Demirci</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Exhaled breath condensate</keyword>
  <keyword>allogeneic stem cell transplantation</keyword>
  <keyword>pulmonary complications</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

